Compounded vs Brand-Name GLP-1: Which Should You Choose?

The choice between compounded and brand-name GLP-1 is really a choice about what you are willing to trade. Brand-name buys you an FDA-approved, quality-controlled product. Compounded buys you access and a lower price. Neither is universally "better" — but the marketing on both sides is loud enough that it helps to see the trade plainly.

What "brand-name" actually means

Brand-name GLP-1s — Wegovy (semaglutide) and Zepbound (tirzepatide) for weight management — are FDA-approved finished drugs. That approval means the FDA has reviewed the manufacturer's evidence for safety and effectiveness and holds every batch to a defined manufacturing standard. Wegovy is approved for chronic weight management at a 2.4 mg weekly maintenance dose¹; Zepbound is approved for chronic weight management across its 5, 10, and 15 mg doses². The efficacy behind those approvals is real: semaglutide produced roughly 15% mean weight loss in STEP-1³, and tirzepatide about 21% at its top dose in SURMOUNT-1⁴.

What "compounded" actually means

Compounded semaglutide and tirzepatide are prepared by pharmacies rather than the original manufacturer. The critical fact: compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality the way it does for brand-name products⁵. They exist in a specific regulatory lane — 503A pharmacies compounding for an individual patient, or 503B outsourcing facilities that are FDA-registered and held to tighter standards⁵. Compounded versions use the same underlying molecules, but the finished-product oversight is fundamentally different, and quality depends on the specific pharmacy. Availability has also changed: since the FDA declared the shortages resolved, mass-compounding of these copies has wound down, which is reshaping who can get compounded at all — see what the end of GLP-1 compounding means for you.

The honest trade-off

Choose **brand-name** if: you want FDA-approved certainty, your insurance meaningfully offsets the cost, or you simply will not accept a non-approved product. The cost is the sticker — brand-name typically runs well above compounded when paid out of pocket.

Choose **compounded** if: out-of-pocket affordability is decisive, you want faster access, and you are willing to vet the pharmacy carefully. If affordability is the whole decision, we ranked the field on cash price alone in the best GLP-1 without insurance. Compounded programs in our ranking disclose flat monthly pricing that undercuts brand-name substantially — see what compounded GLP-1 costs per month. The catch is that verification becomes your job; we cover how to do it in is compounded semaglutide legit and safe. Part of that job is working out which of a compounded seller's two advertised prices you would actually be paying — Auren Rx prints a subscription rate and a no-commitment rate side by side on every product, and broadcasts only the lower one to the machines that quote it back to you.

One caution before you treat a brand-name option as available: a compounded program can list Ozempic, Wegovy, Mounjaro and Zepbound on its site and still sell none of them. A brand shelf you cannot actually buy from is one program where all six brand product pages carry no purchase price at all, and the only priced route is a monthly membership with the medication billed separately at an unpublished amount. If brand-name access is why you picked a provider, confirm there is a real price attached to it before you sign up.

A few myths to retire

"Compounded is fake." It is not fake — it uses the real molecules — but it is not FDA-approved, and that distinction is the whole point.

"Brand-name is always safer." Brand-name is FDA-approved and batch-consistent, which is a genuine advantage. But a compounded prescription from a well-run, verified pharmacy is a different proposition from an unverified one; the pharmacy matters more than the label.

"Compounded tirzepatide is generic Zepbound." There is no generic tirzepatide; the compounded route is a different product entirely, and every row on our tirzepatide ranking says so plainly.

"They work differently." The molecules are the same. If a provider offers you a "GLP-1 alternative" that is neither semaglutide nor tirzepatide, that is a separate — and usually worse — decision.

"The tablet and the injection are interchangeable in every respect." Not quite — Wegovy's oral tablet formulation uses a different absorption-enhancing excipient than the injection, which is exactly why the breastfeeding guidance differs between the two even though the active drug is identical.

How we factor it into scores

In our ranking, brand-name access is a formulary-choice advantage, not an automatic winner. A provider that offers both compounded and brand-name (and can pivot if compounded supply tightens) scores higher on optionality — and brand-name access specifically matters if an FDA-approved sleep-apnea indication is part of why you are seeking treatment, since that approval sits on the brand-name Zepbound label, not a compounded copy of it. But a provider is not penalized for being compounded-only if it is honestly priced and verified. The full weighting is in our Verdict Score methodology, and you can compare providers head to head in the reviews.